Kidney international reports · 2026
Predicting High-Risk CKD in Japanese People: Model Development and Validation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kosugi Takaaki, Eriguchi Masahiro, Yoshida Hisako, Tasaki Hikari, Matsui Masaru, Iseki Kunitoshi, Fujimoto Shouichi, Konta Tsuneo, Moriyama Toshiki, Yamagata Kunihiro, Narita Ichiei, Kasahara Masato, Shibagaki Yugo, Kondo Masahide, Asahi Koichi, Watanabe Tsuyoshi, Tsuruya Kazuhiko
Аннотация
INTRODUCTION: Validated risk equations are recommended to identify patients at high risk of chronic kidney disease (CKD) progression; however, few models are applicable for early identification in primary care. This study developed and validated a predictive model to estimate the risk of progression to high-risk CKD according to the Kidney Disease: Improving Global Outcomes (KDIGO) risk classification.
METHODS: This study used a nationwide Japanese health checkup cohort (2008-2014). The primary outcome was meeting the KDIGO high-risk CKD criteria at 5 years. The variables were selected using the least absolute shrinkage and selection operator method. The model was developed using Cox regression analysis in the Western Japan cohort and externally validated in the Eastern Japan cohort. A nomogram was constructed on the basis of this model to facilitate its clinical application. Net benefit was assessed using decision curve analysis.
RESULTS: The development and validation cohorts included 295,083 (13,453 events) and 119,225 (4593 events) participants, respectively. Age, sex, body mass index (BMI), systolic blood pressure (SBP), hemoglobin A1c (HbA1c), triglycerides (TG), uric acid (UA), estimated glomerular filtration rate, proteinuria, use of medication for hypertension and diabetes, smoking, and a history of stroke were selected as predictors. Discrimination and calibration were good in both the development cohort (C-index, 0.816; calibration slope, 0.998) and the validation cohort (C-index = 0.818; calibration slope = 1.042). Decision curve analysis confirmed the net benefit of the model.
CONCLUSIONS: A prediction model was developed and validated to facilitate the identification of individuals at high risk of CKD progression in primary care.
METHODS: This study used a nationwide Japanese health checkup cohort (2008-2014). The primary outcome was meeting the KDIGO high-risk CKD criteria at 5 years. The variables were selected using the least absolute shrinkage and selection operator method. The model was developed using Cox regression analysis in the Western Japan cohort and externally validated in the Eastern Japan cohort. A nomogram was constructed on the basis of this model to facilitate its clinical application. Net benefit was assessed using decision curve analysis.
RESULTS: The development and validation cohorts included 295,083 (13,453 events) and 119,225 (4593 events) participants, respectively. Age, sex, body mass index (BMI), systolic blood pressure (SBP), hemoglobin A1c (HbA1c), triglycerides (TG), uric acid (UA), estimated glomerular filtration rate, proteinuria, use of medication for hypertension and diabetes, smoking, and a history of stroke were selected as predictors. Discrimination and calibration were good in both the development cohort (C-index, 0.816; calibration slope, 0.998) and the validation cohort (C-index = 0.818; calibration slope = 1.042). Decision curve analysis confirmed the net benefit of the model.
CONCLUSIONS: A prediction model was developed and validated to facilitate the identification of individuals at high risk of CKD progression in primary care.